Clonal Heterogeneity Assessed by Flow Cytometry in B-Cell Lymphomas Arising From Germinal Centers
|
|
- Bethanie Henderson
- 5 years ago
- Views:
Transcription
1 Hematopathology / CLONAL HETEROGENEITY IN B-CELL LYMPHOMAS Clonal Heterogeneity Assessed by Flow Cytometry in B-Cell Lymphomas Arising From Germinal Centers Mar Bellido, MD, 1 Enriqueta Rubiol, 1 Josep Ubeda, 1 Camino Estivill, 1 Granada Perea, MD, 1 Joana Rego-Araujo, 1 Anna Aventín, MD, 1 Ramón Bordes, MD, 2 Jorge Sierra, MD, 1 and Josep F. Nomdedéu, MD 1 Key Words: Flow cytometry; Follicular; Lymphoma; Transformation; Burkitt lymphoma; Diffuse large cell lymphoma Abstract Patients with mature follicular B-cell lymphomas develop aggressive non-hodgkin lymphomas (NHLs) during disease progression. It is controversial whether most diffuse large B-cell lymphomas (DLBCLs) and Burkitt lymphomas (BLs) emerge as de novo lymphomas or from an original follicular lymphoma. To distinguish clonally related populations in aggressive NHL, we studied the immunophenotypic features of 18 consecutive samples from 16 patients. Three flow cytometric patterns were distinguished: (1) a homogeneous neoplastic population of large B cells with phenotypic features of follicular center cells; (2) 2 atypical populations of B cells, small monoclonal B cells, and large B cells with loss of some surface antigens; and (3) 2 clonal populations of small and large B cells sharing the same light-chain isotype. The 3 flow cytometric patterns were observed, respectively, in de novo DLBCL and BL, transformation into BL, and transformation into DLBCL. Flow cytometric data can provide valuable information about the natural history of NHL. Non-Hodgkin lymphomas (NHLs) arising from germinal centers may display different morphologic features. Three categories are distinguished according to the World Health Organization (WHO) classification 1 : follicular lymphomas (FLs) graded by the number of large cells and the presence of diffuse areas composed of large cells, diffuse large B-cell lymphomas (DLBCLs), and Burkitt lymphomas (BLs). These entities share morphologic, phenotypic, and molecular features. 2-4 DLBCLs and BLs can emerge de novo or as a result of transformation from FLs. 5-8 These lymphomas show phenotypic features of follicular B cells, ie, positivity against CD19, CD22, and CD10, but there is no specific immunophenotypic profile associated with each category. Heterogeneous molecular lesions have been identified, ie, rearrangements of the bcl-2 proto-oncogene due to the t(14,18) (q32;q21) chromosomal translocation in FLs, rearrangements of the bcl-6 proto-oncogene in de novo DLBCLs, and c-myc rearrangements in BLs. However, these are not specific to one entity and have been observed during the progression and transformation of FLs into more advanced lymphomas. 6,7,9-15 Overlapping biologic features exist among these lymphomas. According to their natural history, aggressive NHLs can be separated into de novo and transformed NHLs. Commonly, the existence of a lymphoma history and conventional molecular methods showing the same V/(D)/J junction rearrangement in small and large malignant B lymphocytes has been used to demonstrate the transformed origin of an aggressive NHL. However, the introduction of multiparametric techniques in hematology, such as flow cytometry, enables a rapid detection of different subsets of clonally related cells from 1 sample in a single procedure. 16,17 We studied samples from 16 patients with aggressive NHLs with 864 Am J Clin Pathol 2002;117: American Society for Clinical Pathology
2 Hematopathology / ORIGINAL ARTICLE or without a history of FL. The aims of this work were to define the usefulness of flow cytometry as a routine laboratory method to identify different B-cell clones and to deduce the natural history of NHLs with a common origin in germinal centers. Materials and Methods Patient and Sample Selection Between January 1997 and December 2000, 18 samples from 16 consecutive adult patients were studied. Samples were chosen if they had immunophenotypic features of follicular center origin 18 and if they represented DLBCL and BL according to the WHO classification. 1 Monoclonality was defined by flow cytometry when there was evidence of surface immunoglobulin (sig) light-chain restriction, although a homogeneous lack of expression of sig associated with an abnormal immunophenotype (ie, not detected in normal B cells) was regarded as a signal for the malignant nature of the B cells. 19,20 Samples were peripheral blood (n = 3), bone marrow (n = 10), and lymph node cell suspensions (n = 5). In all cases, the fraction of malignant cells was 50% or more. One case (case 7) showed a posttransplant lymphoproliferative disorder with a BL diagnosis. The samples were studied by cytologic and histologic analysis and by immunophenotyping. All samples were examined for the presence of bcl-2 rearrangements using a long-distance polymerase chain reaction (PCR) approach, 21 and cases with a diagnosis of BL were analyzed for the presence of c-myc gene rearrangements by Southern blot analysis. 22 A conventional cytogenetic study 23 was performed in 7 cases (2, 3, 5, 8, 10, 13, and 14). All samples were obtained at diagnosis, and dates, type of sample, and percentage of infiltration were recorded. Morphologic Assessment Morphologic features of these lymphomas were assessed on lymph nodes, bone marrow sections, and peripheral blood samples using standard techniques. Slides were stained with H&E for light microscopy. On the basis of the WHO classification, 1 samples were classified as BL (n = 11) or DLBCL (n = 5). BL showed the characteristic cytologic (vacuolated and basophilic cells) and histologic picture (a starry sky pattern) associated with a very high growth fraction (>96% Ki-67+ cells). In lymph node biopsy specimens, an immunochemical analysis of CD20, CD10, CD79a, Ki-67, CD5, and CD3 monoclonal antibodies (purchased from DAKO, Glostrup, Denmark) and bcl-2 and bcl-6 protein expression was performed. The reaction for bcl-2 was classified as positive when more than 10% of the tumor cells showed cytoplasmic staining. Flow Cytometric Analysis Peripheral blood, bone marrow, and freshly disaggregated lymph node suspensions were analyzed without additional preparation. The number of cells was quantified by microscopy and adjusted to in each tube. For sample preparation, a stain, lyse, and wash procedure was used; erythrocytes were lysed by means of FACS Lysing solution (Becton Dickinson [BD], San Jose, CA). Clonality study of B lymphocytes was undertaken using a triple reagent consisting of a combination of kappa fluorescein isothiocyanate (FITC), lambda phycoerythrin (PE), and CD19- PE/Cy5 in a single tube (kappa/lambda, Simultest, BD; CD19, Caltag, San Francisco, CA). Each clonal sample was studied using a panel of triple monoclonal antibodies (FITC, PE, PE/Cy5): FMC7-FITC (FMC7, Harlan Sera-Lab, Belton, England)/CD5-PE (L17F12, BD)/ (SJ25C1, Caltag); CD22-FITC (S-HCL-1, DAKO)/CD23-PE (EBVCS-5, BD)/ (Caltag); CD103-FITC (B- Ly7, Immunoquality, Groningen, the Netherlands)/CD25-PE (ZA3, BD)/ (Caltag); CD10-FITC (W8E7, BD)/CD11c-PE (D 12, BD)/ (Caltag); and CD79b-FITC (SN8, DAKO)/CD20-PE (L 27, BD)/CD10- PE/Cy5 (HI10a, Pharmingen, San Diego, CA). Measurements were performed on a FACScan flow cytometer using the LYSIS-II software for data acquisition and the PAINT-A-GATE PRO software for data analysis (BD). The analysis was performed on gated lymphoid cells, and although 15,000 events per tube were measured in all samples, CD19+ cells were selectively introduced for clonality analysis. The positivity threshold was 20% for all markers. Molecular Studies DNA extraction was performed by digestion with Proteinase K, extraction by the salting out method, and precipitation with ethanol. 24 A long-distance PCR approach using the protocol published by Akasaka et al 21 was used to study bcl-2 rearrangements. Briefly, we used 100 ng of genomic DNA, a 2.5-mmol/L concentration of each deoxynucleoside triphosphate, 20 pmol of each primer, and 2.5 U Taq DNA polymerase (TaKaRa LA Taq polymerase, Takara Shuzo, Kyoto, Japan), in a final volume of 50 µl. Longdistance PCR conditions were as follows: 1 cycle of denaturation (94 C for 1 minute); 30 cycles of denaturation (98 C for 20 seconds), and annealing (68 C for 20 minutes) followed by a cycle of extension (72 C for 16 minutes). The sequence of the primers used to detect the immunoglobulin/bcl-2 fusion genes has been reported previously. 21 Southern Blot Analysis Five micrograms of DNA were digested using EcoRI and HindIII (New England Biolabs, Beverly, MA) restriction enzymes. DNA was separated on a 0.7% agarose gel and American Society for Clinical Pathology Am J Clin Pathol 2002;117:
3 Bellido et al / CLONAL HETEROGENEITY IN B-CELL LYMPHOMAS Table 1 Diagnosis and Phenotypic and Genotypic Characteristics of Aggressive Non-Hodgkin Lymphomas From the Germinal Center Case FMC7/CD5/ CD22/ CD10/CD11c/ CD79a/ kappa/lambda/ Karyo- No. Diagnosis Sample FSC CD19 CD23/CD19 CD19 CD20/CD10 CD19 bcl-2 type c-myc Pattern * 1 FL transformation PB +++ / /+ (60%) +/ /+ +/ /+ (60%) +/ /+ (60%) Negative sig (60%) Negative ND G 2 to BL + / /+ (40%) / /+ (40%) +/+/+(40%) +/ /+ (40%) 2 FL transformation BM ++ +/ /+ +/ /+ +/ /+ +/+/+ Negative sig (95%); Negative t(8;14) R 2 to BL +/ /+ (5%) 3 FL transformation BM ++ +/ /+ +/ /+ +/ /+ +/+/+ /+/+ Positive Complex G 2 to BL 4 De novo BL BM ++ +/ /+ +/ /+ +/+/+ Negative sig Negative t(8;14) ND 1 5 FL transformation PB +++ / /+ +/ /+ (95%) +/ /+(95%) +/+/+(100%) +/ /+ (100%) Positive ND ND 3 to DLBCL + +/+/+(5%) / /+ (5%) 6 De novo DLBCL BM ++ +/ /+ +/ /+ / /+ +/+/+ +/ /+ Negative ND ND 1 7 De novo BL BM ++ +/ /+ +/ /+ +/ /+ +/+/+ /+/+; Negative ND R 1 polyclonal (4%) 8 De novo BL BM ++ +/ /+ +/ /+ +/ /+ +/+/+ +/ /+; Positive t(8;14) G 1 polyclonal (4%) 9 De novo BL, HIV+ LN ++ +/ /+ +/ /+ +/ /+ +/+/+ +/ /+ Negative ND G 1 10 De novo BL, HIV+ BM ++ ND +/ /+ +/ /+ +/+/+ /+/+ Negative Negative R 1 11 De novo BL, HIV+ PB ++ ND +/ /+ +/ /+ +/+/+ Negative sig Negative ND G 1 BM +/ /+; poly- ND G clonal (1%) 12 FL transformation LN +++ / /+ (80%) +/ /+ (80%) +/ /+ (80%) +/+/+ +/ /+ (100%) Positive ND ND 3 to DLBCL LN + +/ /+(20%) +/+/+(20%) / /+ (20%) +/ /+ ND ND 13 De novo BL, HIV+ BM +++ +/ /+ +/ /+ +/ /+ +/+/+ Negative sig; Negative t(8;14) Positive 1 polyclonal (15%) 14 De novo BL BM ++ +/ /+ +/ /+ +/ /+ +/+/+ +/ /+ Negative ND Positive 1 15 De novo DLBCL LN ++ +/ /+ +/ /+ / /+ +/+/+ /+/+ Positive ND ND 1 16 De novo DLBCL LN +++ +/ /+ +/ /+ / /+ +/+/+ +/ /+ Negative ND ND 1 BL, Burkitt lymphoma; BM, bone marrow; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; FSC, forward scatter; G, germinal; LN, lymph node; ND, not done; PB, peripheral blood; R, rearranged; sig, surface immunoglobulin; +, weak; ++, moderate; +++, strong;, negative. * See the Results section for an explanation of the immunophenotypic patterns. transferred to nylon membranes (Amersham, Buckinghamshire, England), which were hybridized with the MC413RC probe labeled with phosphorus 32 deoxycytidine triphosphate by the random primer extension method. Filters were washed in 0.2 sodium chloride sodium citrate/0.5% sodium dodecyl sulfate for 2 hours at 65 C and then autoradiographed using intensifying screens. 22 Cytogenetic Analysis Cytogenetic studies were undertaken on fresh lymphoma cells after short-term culture without stimulation. Chromosomes were banded using G banding, and chromosomal abnormalities were described according to the International System for Human Cytogenetic Nomenclature. 23 Results Patient Characteristics We studied 18 samples from 16 patients. Two samples were analyzed in 2 cases (11 and 12) Table 1. All patients were adults, 7 men and 9 women. The disease stage at diagnosis was III or IV in all cases. All patients with DLBCL were categorized as having a high-risk international prognostic index (score of 4-5). Five patients had extranodal involvement at diagnosis. The extranodal sites affected were the leg, pelvis, retroperitoneal mass, intestine, and heart. Even in these cases, there was a concomitant lymph node enlargement that was biopsied to establish the diagnosis. Test results for HIV were positive in 4 cases (Table 1). Only 2 patients remained alive 5 months after the diagnosis. One of these was diagnosed with a posttransplant BL. Flow Cytometric Results In all samples, neoplastic B cells showed phenotypic features of follicular cells. 18 They showed positivity against CD10-PE/Cy5 and/or CD10-FITC, CD20, CD22, CD19, HLA-DR, and ccd79a, with negativity against CD5, CD34, and terminal deoxynucleotidyl transferase. Interestingly, all samples were negative for CD23, an antigen commonly expressed by mature B cells. 18 Five lymphoma samples showed no sig expression. The immunophenotypic profile of cases in which a normal population of B cells was detected revealed positivity for FMC7, CD19, CD20, CD22, CD23, and HLA-DR and negativity for CD5, CD10-PE/Cy5, and CD10-FITC with a polyclonal expression pattern of sig. We found 3 immunophenotypic patterns according to the antigenic profile of malignant B cells Figure 1 : (1) Pattern 1 was a homogeneous monoclonal population of large B cells 866 Am J Clin Pathol 2002;117: American Society for Clinical Pathology
4 Hematopathology / ORIGINAL ARTICLE A B SSC Height 1, ,024 FSC Height CD22-FITC CD23-PE SSC Height 1, ,024 FSC Height CD22-FITC CD23-PE CD20-PE C SSC Height CD10-PE/Cy5 (high forward scatter [FSC] side scatter [SSC] distribution) (12 samples from 11 patients; cases 4, 6-11, and 13-16). This pattern was considered as representative of de novo aggressive NHL, BL, or DLBCL. Three samples from 3 patients with BL did not express sig, whereas samples from all patients with DLBCL showed sig expression (Figure 1A). (2) Pattern 2 included 2 atypical subpopulations of B cells constituted by small and large B cells (cases 1-3). The first subpopulation corresponded to a small clonal B-cell population, whereas the other subpopulation represented larger atypical cells; these larger cells had some different immunophenotypic features with respect to the small B-cell population (sig and CD23 loss and CD10-FITC gain) (Figure 1B). (3) Pattern 3 included 2 monoclonal subpopulations of B cells showing the same light-chain isotype (3 samples from 2 patients; cases 5 and 12). These 2 subpopulations could be distinguished because one of them was reactive against CD10-PE/Cy5 but not against CD10-FITC, and it had low FSC/SSC distribution, lambda CD10-FITC CD79b-FITC kappa 1, ,024 FSC Height CD23-PE lambda CD22-FITC CD20-PE CD19 CD10-FITC CD10-FITC kappa kappa CD10-PE/Cy5 CD10-FITC CD20-PE kappa Figure 1 Flow cytometric patterns. A, Immunophenotypic pattern 1 detected in de novo aggressive non-hodgkin lymphoma samples. A homogeneous population of clonal B cells is shown (pink). B, Immunophenotypic pattern 2 detected in follicular lymphomas transformed to Burkitt lymphomas. The presence of 2 B-cell subsets is shown: small B cells showed surface immunoglobulin light chain expression (blue), whereas the other subpopulation of larger B cells did not express surface immunoglobulin (pink). Both subpopulations had different expression patterns of the CD10 fluorescein isothiocyanate (FITC) and CD20 antigens. C, Immunophenotypic pattern 3 detected in follicular lymphomas transformed to diffuse large B-cell lymphomas. The presence is shown of two B-cell subsets with expression of the same surface immunoglobulin but different forward light scatter characteristics and CD10-FITC/CD23 reactivity. Small clonal B cells (blue) and large clonal B cells (pink) are shown. FSC, forward scatter; PE, phycoerythrin; SSC, side scatter. whereas the other subpopulation showed CD10-FITC and CD10-PE/Cy5 expression with high FSC/SSC distribution and loss of CD23 reactivity (Figure 1C). The former population was compatible with a low-grade lymphoma, and the second corresponded to transformation to DLBCL. These atypical patterns should be distinguished from the simultaneous detection of mature normal B cells and normal B-cell precursors in bone marrow samples. Normal precursors did not show atypical expression of B-cell differentiation antigens or expression of sig. Mature normal B cells showed negativity against CD10-FITC (W8E7) and a polyclonal sig pattern Figure 2. Correlation Among Clinical, Morphologic, Phenotypic, and Molecular Findings Samples classified within immunophenotypic pattern 1 could be separated into 2 categories according to morphologic features and medical history: (1) de novo DLBCL (n = 3; lambda American Society for Clinical Pathology Am J Clin Pathol 2002;117:
5 Bellido et al / CLONAL HETEROGENEITY IN B-CELL LYMPHOMAS cases 6, 15, and 16) and (2) de novo BL (n = 8; cases 4, 7-11, 13, and 14). De novo DLBCLs were distinguished from de novo BLs by flow cytometry because large B cells of the DLBCL cases showed positivity against CD10-PE/Cy5 with negativity against CD10-FITC, and they showed homogeneous expression of sig. In cases of de novo BL, samples were positive for both CD10-PE/Cy5 and CD10-FITC, with some cases showing lack of expression of sig. Analysis of bcl-2 rearrangements in this group demonstrated the t(14;18) chromosomal translocation in 2 of 11 cases, one being diagnosed as de novo BL (case 8) and the other as de novo DLBCL (case 15). Involvement of the 8q24 band was found in 3 of 8 cases within this group (cases 4, 8, and 13), but we found no association with a specific antigenic profile. Simultaneous detection of the t(14;18) and t(8;14) chromosomal translocations was found in 1 case (case 8). Of 3 cases classified in the flow cytometric pattern 2 (transformation to BL), 2 characteristically showed loss of some surface antigens at the time of transformation (CD20, sig, or CD23). One case (case 2) showed a t(8;14) chromosomal translocation, and another case (case 3) showed complex cytogenetic abnormalities associated with the t(14;18)(q21;q32). The complex karyotype suggests the accumulation of several molecular lesions in different steps during the progression and transformation from mature B cells to a blastic phase. The 2 cases with flow cytometric pattern 3 (n = 3 samples) showed bcl-2 rearrangements resulting from the t(14;18)(q21;q32) chromosomal translocation, and all patient samples showed sig expression in small and large B cells, as evidenced by flow cytometry. Discussion The immunophenotypic changes associated with FL transformation have not been characterized clearly. To determine the usefulness of flow cytometry in distinguishing de novo from transformed aggressive NHL, we analyzed the immunophenotypic features of different B-cell subpopulations in DLBCL and BL samples. We found the following immunophenotypic traits that could be associated with the different biologic behavior of these lymphomas: (1) CD10- FITC (W8E7) was expressed commonly by aggressive NHL (de novo and transformed). (2) In the cases in the present series with 2 clonal B-cell populations (small and large cells), the small cells were CD23+, and the large cells were CD23, possibly suggesting that CD23 was lost during the transformation into DLBCL or BL. CD23 is a molecule that recognizes the lymphocyte low-affinity receptor for IgE (Fc epsilon RII), an antigen involved in B-cell differentiation. (3) The detection of 2 monoclonal populations of small and slg+/ FC Pattern 1 slg+/ FC Pattern 2 slg+/ FC Pattern 3 Figure 2 Schematic diagram illustrating the 3 flow cytometric (FC) patterns described. Polyclonal B lymphocytes are depicted in blue and green. Red cells correspond to neoplastic B lymphocytes. Note the small clonal B cells present in FC patterns 2 and 3. sig, surface immunoglobulin. large CD19+ cells in the same sample with the same isotype of sig suggests a common single-cell origin (Figure 1). (4) Detection in the same sample of small B lymphocytes with monoclonal expression of sig and large B cells with lack of sig expression could be a sign of transformation into an aggressive lymphoma, especially when it is associated with other antigenic losses (ie, CD23). The histologic features of cases classified as transformed DLBCL or BL were reviewed in comparison with earlier tumor samples from the same patients, and the diagnosis of transformed NHL was confirmed. Comparison of de novo and transformed aggressive lymphomas also revealed common immunophenotypic features, reflecting the same origin in germinal centers. Both entities showed an immunophenotypic profile typical of mature B cells of follicular center origin, 18,25 ie, positivity against CD19, CD20, CD10-PE/Cy5, CD22, and CD23, whereas they showed variable positivity against the FMC7 and CD79b monoclonal antibodies. Flow cytometry is, thus, a very useful complementary tool to study biologically aggressive variants of FL. Flow cytometry has been used to analyze different populations of B cells in cases of Richter syndrome. 26,27 These studies reported a common immunophenotype in mature and 868 Am J Clin Pathol 2002;117: American Society for Clinical Pathology
6 Hematopathology / ORIGINAL ARTICLE transformed B cells of chronic lymphocytic leukemia, suggesting a common origin in a single progenitor cell. We report our results using triple immunostaining and confirm the usefulness of flow cytometry as a diagnostic method to study subclones in FL and transformed aggressive NHL. Five cases classified as de novo BL did not show sig expression (Table 1). The lack of expression of sig is an uncommon but a previously reported finding in NHLs. 19,20 It is believed that the lack of sig expression reflects a posttranscriptional defect, given that rearrangements of the heavychain immunoglobulin gene have been evidenced in some of these cases. 19 This finding is common in cases of mediastinal large B-cell lymphoma with sclerosis, nonfollicular center cell lymphomas, and chronic lymphocytic leukemia. 20 BLs also may lack the expression of sig measured by flow cytometry as shown in this study. In these cases, sig loss also could be a sign of the apoptotic process. Detection of various populations of B cells also occurs in a substantial proportion of bone marrow samples that show normal progenitors of B lymphocytes and in cases of peripheral blood samples of leukemic NHL. In bone marrow samples of BL or DLBCL, the detection of CD34+/terminal deoxynucleotidyl transferase+/cd23 /CD20 /sig cells with lack of sig expression identifies normal B-cell progenitors. The normal B-cell compartment in peripheral blood samples in cases of leukemic NHL is characterized by a clonality assay showing a polyclonal sig pattern and normal positivity for CD20 and CD23. The present study revealed the coexistence of normal and neoplastic B lymphocytes in 4 cases (2 bone marrow and 2 peripheral blood samples). The identification of these B-cell populations also was used as an indirect marker of the level of peripheral blood contamination and the residual hematopoietic normal tissue in bone marrow samples. The t(8;14)(q24;q32) and t(14;18)(q32;q21) chromosomal translocations are frequent in BL and FL, respectively, but they also have been observed in a proportion of cases of DLBCL. It is noteworthy that all lymphoma cases with the t(14;18)(q32;q21) showed sig expression. In patients with de novo BL, 50% of cases (4/8) showed HIV positivity, and 2 of these 4 showed c-myc rearrangements when a third exon probe was used. This underscores the importance of testing for HIV infection in all cases of BL. The coexistence of the two t(8;14) and t(14;18) chromosomal translocations was observed in only 1 patient (case 8). Although the detection of the t(14;18) chromosomal translocation could suggest transformation from a previous FL, this patient had a diagnosis of de novo BL, and he had no medical history of lymphoma. Recently, the detection of the t(14;18) chromosomal translocation has been reported in de novo hematologic malignant neoplasms. 28 These findings suggest that although de novo aggressive NHLs are phenotypically similar to transformed BLs or DLBCLs, different immunophenotypic patterns may be associated with these categories. A clear definition of the various immunophenotypic patterns that occur in aggressive NHL is a key to understanding the natural history and biologic behavior of these diseases. Flow cytometry could be a useful complementary tool for distinguishing the nature of NHLs and for designing better therapeutic strategies. From the Departments of 1 Hematology and 2 Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Address reprint requests to Dr Nomdedéu: Laboratori d Hematologia, Hospital de la Santa Creu i Sant Pau, C/Sant Antoni M. Claret 167, Barcelona, Spain. References 1. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; Matolcsy A. High-grade transformation of low-grade non- Hodgkin s lymphomas: mechanisms of tumor progression. Leuk Lymphoma. 1999;34: Matolcsy A, Schattner EJ, Knowles DM, et al. Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Eur J Immunol. 1999;29: Capello D, Gaidano G. Molecular pathophysiology of indolent lymphoma. Haematologica. 2000;85: Foran JM, Apostolodis J, Papamichael D, et al. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann Oncol. 1998;9: Volpe G, Vitolo U, Carbone A, et al. Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosomes Cancer. 1996;16: Gascoyne RD, Adomat SA, Krajewski S, et al. Prognostic significance of bcl-2 protein expression and bcl-2 gene rearrangements in diffuse aggressive non-hodgkin s lymphoma. Blood. 1997;90: Zelenetz AD, Chen TT, Levy R. Histological transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell. J Exp Med. 1991;173: Macpherson N, Lesack D, Klasa R, et al. Small noncleaved, non-burkitt s (Burkitt-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol. 1999;17: Yano T, Jaffe ES, Longo DL, et al. MYC rearrangements in histologically progressed follicular lymphomas. Blood. 1992;80: Lossos IS, Levy R. High-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the bcl-6 gene. Blood. 2000;15: Pinyol M, Cobo F, Bea S, et al. P16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-hodgkin s lymphomas. Blood. 1998;91: Tormo M, Tari AM, McDonnell TJ, et al. Apoptotic induction in transformed follicular lymphoma cells by bcl-2 downregulation. Leuk Lymphoma. 1998;30: American Society for Clinical Pathology Am J Clin Pathol 2002;117:
7 Bellido et al / CLONAL HETEROGENEITY IN B-CELL LYMPHOMAS 14. Matolcsy A, Casali P, Warnke RA, et al. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated bcl-2 gene. Blood. 1996;88: Sande CA, Yano T, Clark HM, et al. p53 mutation is associated with progression in follicular lymphomas. Blood. 1993;82: Orfao A, Schmitz G, Brando B, et al. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem. 1999;45: Batata A, Shen B. Diagnostic value of clonality of surface immunoglobulin light and heavy chains in malignant lymphoproliferative disorders. Am J Hematol. 1993;16: Bellido M, Rubiol E, Ubeda J, et al. Flow cytometry using the monoclonal antibody CD10-PE/Cy5 is a useful tool to identify follicular lymphoma cells. Eur J Haematol. 2001;66: Kaleem Z, Zehnbauer BA, White G, et al. Lack of expression of surface immunoglobulin light chains in B-cell non- Hodgkin lymphomas. Am J Clin Pathol. 2000;113: Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8: Akasaka T, Akasaka H, Yonetani N, et al. Refinement of the bcl-2/immunoglobulin heavy chain fusion gene in t(14;18) (q21;q32) by polymerase chain reaction amplification for long targets. Genes Chromosomes Cancer. 1998;21: Dalla-Favera R, Bregni M, Erikson J, et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982;79: Aventin A, Mecucci C, Guanyabens C, et al. Variant t(2;18) translocation in a Burkitt conversion of follicular lymphoma. Br J Haematol. 1990;74: Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16: Tbakhi A, Edinger M, Myles J, et al. Flow cytometric immunophenotyping of non-hodgkin s lymphomas and related disorders. Cytometry. 1996;25: Delsol G, Laurent G, Kuhlein E, et al. Richter s syndrome: evidence for the clonal origin of the two proliferations. Am J Clin Pathol. 1981;76: Sun T, Susin M, Desner M, et al. The clonal origin of two cell populations in Richter s syndrome. Hum Pathol. 1990;21: Stamatoullas A, Buchonnet G, Lepretre S, et al. De novo acute B cell leukemia/lymphoma with t(14;18). Leukemia. 2000;14: Am J Clin Pathol 2002;117: American Society for Clinical Pathology
The spectrum of flow cytometry of the bone marrow
The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests
More informationCase 3. Ann T. Moriarty,MD
Case 3 Ann T. Moriarty,MD Case 3 59 year old male with asymptomatic cervical lymphadenopathy. These images are from a fine needle biopsy of a left cervical lymph node. Image 1 Papanicolaou Stained smear,100x.
More informationImmunopathology of Lymphoma
Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.
More informationLack of Surface Immunoglobulin Light Chain Expression by Flow Cytometric Immunophenotyping Can Help Diagnose Peripheral B-Cell Lymphoma
Hematopathology / SURFACE IMMUNOGLOBULIN LIGHT CHAIN NEGATIVE PERIPHERAL B-CELL LYMPHOMA Lack of Surface Immunoglobulin Light Chain Expression by Flow Cytometric Immunophenotyping Can Help Diagnose Peripheral
More informationDifferential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital
Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic
More information7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour
7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic
More informationCase Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent
Int J Clin Exp Med 2014;7(1):307-311 www.ijcem.com /ISSN:1940-5901/IJCEM1311029 Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Qilin Ao 2, Ying Wang 1, Sanpeng Xu 2,
More informationSuccessful flow cytometric immunophenotyping of body fluid specimens
Successful flow cytometric immunophenotyping of body fluid specimens Fiona E. Craig, MD Division of Hematopathology Mayo Clinic Arizona 2017 MFMER slide-1 Financial disclosure No conflicts 2017 MFMER slide-2
More informationThe patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was:
Case History An 86 year old male was admitted to hospital with chest infection. Haematological examination subsequently revealed the following: Hb- 11.0 g/dl; WBC- 67.1 x 10^9/l; PLT- 99 x10^9/l; RBC-
More informationMolecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU
Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Lecture outline Time 10:00 11:00 11:15 12:10 12:20 13:15 Content Introduction to lymphoma Review of lymphocyte biology
More informationFlow cytometric evaluation of endoscopic biopsy specimens from patients with gastrointestinal tract B-cell lymphoma: a preliminary report
Jichi Medical University Journal Flow cytometric evaluation of endoscopic biopsy specimens from patients with gastrointestinal tract B-cell lymphoma: a preliminary report Satoko Oka,, Kazuo Muroi,, Kazuya
More informationClassification of Hematologic Malignancies. Patricia Aoun MD MPH
Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences
More informationGray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Tres
Gray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Treseler, MD, PhD University of California San Francisco
More informationV. Acute leukemia. Flow cytometry in evaluation of hematopoietic neoplasms: A case-based approach
V. Acute leukemia Evaluating a sample for an acute leukemia Acute leukemia is a neoplasm of immature myeloid or lymphoid cells characterized by a block in maturation, usually at the stage of an early progenitor
More informationFlow Cytometric Analysis of Surface Light Chain Expression Patterns in B-Cell Lymphomas Using Monoclonal and Polyclonal Antibodies
Hematopathology / Light Chain Expression in B-NHLs Flow Cytometric Analysis of Surface Light Chain Expression Patterns in B-Cell Lymphomas Using Monoclonal and Polyclonal Antibodies Pedro Horna, MD, Horatiu
More informationCritical Analysis and Diagnostic Usefulness of Limited Immunophenotyping of B-Cell Non-Hodgkin Lymphomas by Flow Cytometry
Hematopathology / FLOW CYTOMETRIC IMMUNOPHENOTYPING IN B-CELL NON-HODGKIN LYMPHOMA Critical Analysis and Diagnostic Usefulness of Limited Immunophenotyping of B-Cell Non-Hodgkin Lymphomas by Flow Cytometry
More informationHIGH GRADE B-CELL LYMPHOMA DAVID NOLTE, MD (PGY-2) HUSSAM AL-KATEB, PHD, FACMG DEBORAH FUCHS, MD
HIGH GRADE B-CELL LYMPHOMA DAVID NOLTE, MD (PGY-2) HUSSAM AL-KATEB, PHD, FACMG DEBORAH FUCHS, MD OUTLINE High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements Patient presentation 2008/2016
More informationGENETIC MARKERS IN LYMPHOMA a practical overview. P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute
GENETIC MARKERS IN LYMPHOMA a practical overview P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute B and T cell monoclonalities Rearrangement of immunoglobin and TCR genes may help
More informationCME/SAM. Abstract. Hematopathology / CD103 and CD123 in B-Cell Neoplasia
Hematopathology / CD103 and CD123 in B-Cell Neoplasia Characteristic CD103 and CD123 Expression Pattern Defines Hairy Cell Leukemia Usefulness of CD123 and CD103 in the Diagnosis of Mature B-Cell Lymphoproliferative
More informationLymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC
Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing
More informationPathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e
Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long
More informationADx Bone Marrow Report. Patient Information Referring Physician Specimen Information
ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS
More informationLymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients
Hematopathology / LYMPHOMAS WITH IGM PARAPROTEIN Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients Pei Lin, MD, 1 Suyang Hao, MD, 1* Beverly C. Handy, MD, 2 Carlos E. Bueso-Ramos,
More informationAggressive B-cell Lymphomas Updated WHO classification Elias Campo
Aggressive B-cell Lymphomas Updated WHO classification Elias Campo Hospital Clinic, University of Barcelona Diffuse Large B-cell Lymphoma A Heterogeneous Category Subtypes with differing: Histology and
More informationFlow Cytometric Analysis of Cerebral Spinal Fluid Involvement by Leukemia or Lymphoma
Flow Cytometric Analysis of Cerebral Spinal Fluid Involvement by Leukemia or Lymphoma Maryalice Stetler-Stevenson, M.D., Ph.D. Flow Cytometry Unit, Laboratory of Pathology, DCS, NCI, NIH DEPARTMENT OF
More informationFrom Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport
From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative
More informationCME/SAM. Olga Pozdnyakova, MD, PhD, 1 Svetlana Kondtratiev, MD, 1,2 Betty Li, MS, 1 Karry Charest, 1 and David M. Dorfman, MD, PhD 1.
Hematopathology / New Mastocytosis Flow Cytometry Approach High-Sensitivity Flow Cytometric Analysis for the Evaluation of Systemic Mastocytosis Including the Identification of a New Flow Cytometric Criterion
More informationCitation International Journal of Hematology, 2013, v. 98 n. 4, p The original publication is available at
Title Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma Author(s) So, JCC; Yung, KH; Chu, ML; Wan,
More informationCase Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case
Int J Clin Exp Pathol 2014;7(10):7100-7104 www.ijcep.com /ISSN:1936-2625/IJCEP0001717 Case Report Parotid gland follicular lymphoma lacking both cytoplasmic and surface light chains: a rare case Jenny
More informationMalignant lymphomas are neoplasms that arise from B
Overview of the Role of Molecular Methods in the Diagnosis of Malignant Lymphomas L. Jeffrey Medeiros, MD; Jeanne Carr, PhD Objective. To review the role of molecular genetics in the diagnosis of malignant
More informationThe development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory
The development of clonality testing for lymphomas in the Bristol Genetics Laboratory Dr Paula Waits Bristol Genetics Laboratory Introduction The majority of lymphoid malignancies belong to the B cell
More informationPhenoPath. Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA
PhenoPath Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA C urrent diagnosis of B cell non-hodgkin lymphoma (B-NHL) is based on the 2008 WHO Classification of Tumours of Haematopoietic and Lymphoid
More informationFlow cytometric analysis of B-cell lymphoproliferative disorders
Flow cytometric analysis of B-cell lymphoproliferative disorders David M. Dorfman, M.D., Ph.D. Department of Pathology Brigham and Women s Hospital and Harvard Medical School Boston, MA Objectives Review
More informationDr Prashant Tembhare
Dr Prashant Tembhare docprt@gmail.com FCM very powerful technology in Identification and characterization of neoplastic plasma cells as it allows - simultaneous assessment of multiple antigens large numbers
More informationSH/EAHP WORKSHOP 2017 CASE 210 PRESENTATION
SH/EAHP WORKSHOP 2017 CASE 210 PRESENTATION Jonathon H Gralewski DO, MS, Ginell R Post MD, PhD, Youzhong Yuan MD September 9, 2017 Clinical History 60 year old male with history of c-maf high-risk IgG
More informationDefined lymphoma entities in the current WHO classification
Defined lymphoma entities in the current WHO classification Luca Mazzucchelli Istituto cantonale di patologia, Locarno Bellinzona, January 29-31, 2016 Evolution of lymphoma classification Rappaport Lukes
More informationNon-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)
Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma
More informationFollicular Lymphoma: the WHO
Follicular Lymphoma: the WHO and the WHERE? Yuri Fedoriw, MD Associate Professor of Pathology and Laboratory Medicine Director of Hematopathology University of North Carolina Chapel Hill, NC Disclosure
More informationCD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting
Original Article DOI: 10.21276/APALM.1364 CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting Sakthi Sankari S 1 *, Arjunan A 2, Bhuvaneswari M.G. 2, Sindhuja
More informationRoutine staging in non-hodgkin s lymphomas
Malignant Lymphomas Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas original paper haematologica 2001; 86:934-940 http://www.haematologica.it/2001_09/0934.htm
More informationMethods used to diagnose lymphomas
Institut für Pathologie Institut für Pathologie Methods used to diagnose lymphomas Prof. Dr.Med. Leticia Quintanilla-Fend Molecular techniques NGS histology Cytology AS-PCR Sanger seq. MYC Immunohistochemistry
More informationClinical question. Screening tube. Diagnostic panel MRD. Clinical question
OW CYTOMETRY UPDATES IN LYMPHOPROLIFERATIVE DISORDERS CANCER RESEARCH CENTER IBSAL UNIVERSITY & UNIVERSITY HOSPITAL, SALAMANCA (SPAIN) DISCLOSURES The EuroFlow Scientific Consortium Iamco-chairof receives
More informationImmunophenotyping in the diagnosis of chronic lymphoproliferative disorders
J7 Clin Pathol 1994;47:871-875 871 L eaders~~~~~~~~~~~~~~~~.........;->:>> :*--:-- :- -::-*;:- --::- >:-:;-:: ::;...:::::...::::::::::*::;:;;::;::;::;;:;;:;;::;::;::;;:;;:;:::::::::::::::::: Task Force
More informationDoes the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Histopathology 2012, 61, 1214 1218. DOI: 10.1111/j.1365-2559.2012.04351.x SHORT REPORT Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
More informationCCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma
AJCP /CASE REPORT CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma Yuan Miao, MD, 1,2 Pei Lin, MD, 1 Wei Wang, MD, 1 L. Jeffrey Medeiros, MD,
More information88-year-old Female with Lymphadenopathy. Faizi Ali, MD
88-year-old Female with Lymphadenopathy Faizi Ali, MD Clinical History A 88-year-old caucasian female presented to our hospital with the complaints of nausea, vomiting,diarrhea, shortness of breath and
More informationExtramedullary precursor T-lymphoblastic transformation of CML at presentation
Extramedullary precursor T-lymphoblastic transformation of CML at presentation Neerja Vajpayee, Constance Stein, Bernard Poeisz & Robert E. Hutchison Clinical History 30 year old man presented to the emergency
More informationDiagnostic challenge: Acute leukemia with biphenotypic blasts and BCR-ABL1 translocation
Case Study Diagnostic challenge: Acute leukemia with biphenotypic blasts and BCR-ABL1 translocation Ling Wang 1 and Xiangdong Xu 1,2,* 1 Department of Pathology, University of California, San Diego; 2
More informationFOLLICULARITY in LYMPHOMA
FOLLICULARITY in LYMPHOMA Reactive Follicular Hyperplasia Follicular Hyperplasia irregular follicles Follicular Hyperplasia dark and light zones Light Zone Dark Zone Follicular hyperplasia MIB1 Follicular
More informationCME/SAM. Flow Cytometric Immunophenotyping of Cerebrospinal Fluid Specimens
Hematopathology / Flow Cytometric Immunophenotyping of CSF Specimens Flow Cytometric Immunophenotyping of Cerebrospinal Fluid Specimens Fiona E. Craig, MD, 1 N. Paul Ohori, MD, 2 Timothy S. Gorrill, MD,
More informationAberrant Expression of CD7 in Myeloblasts Is Highly Associated With De Novo Acute Myeloid Leukemias With FLT3/ITD Mutation
Hematopathology / CD7 Expression and FLT3/ITD Mutation in AML Aberrant Expression of CD7 in Myeloblasts Is Highly Associated With De Novo Acute Myeloid Leukemias With FLT3/ITD Mutation Veronica Rausei-Mills,
More informationFLOW CYTOMETRY PRINCIPLES AND PRACTICE. Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018
FLOW CYTOMETRY PRINCIPLES AND PRACTICE Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018 Aims and Objectives Principles of flow cytometry Preparation Steps involved
More informationContents. vii. Preface... Acknowledgments... v xiii
Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...
More informationAggressive B-cell Lymphoma 2013
Aggressive B-cell Lymphoma 2013 Diffuse Large B-Cell Lymphoma Burkitt Lymphoblastic lymphoma Gray zone Intermediate DLBCL/HL Intermediate BL/DLBCL Diffuse Large B-cell lymphoma Common morphology: diffuse
More informationMixed Phenotype Acute Leukemias
Mixed Phenotype Acute Leukemias CHEN GAO; AMY M. SANDS; JIANLAN SUN NORTH AMERICAN JOURNAL OF MEDICINE AND SCIENCE APR 2012 VOL 5 NO.2 INTRODUCTION Most cases of acute leukemia can be classified based
More informationNucleic Acid Testing - Oncology. Molecular Diagnosis. Gain/Loss of Nucleic Acid. Objectives. MYCN and Neuroblastoma. Molecular Diagnosis
Nucleic Acid Testing - Oncology Molecular Diagnosis Nucleic acid based testing in Oncology Gross alterations in DNA content of tumors (ploidy) Gain/Loss of nucleic acids Markers of Clonality Oncogene/Tumor
More informationMolecular Diagnosis. Nucleic acid based testing in Oncology
Molecular Diagnosis Nucleic acid based testing in Oncology Objectives Describe uses of NAT in Oncology Diagnosis, Prediction, monitoring. Genetics Screening, presymptomatic testing, diagnostic testing,
More informationLymphoma and Pseudolymphoma
Lymphoma and Pseudolymphoma Laura B. Pincus, MD Co-Director, Cutaneous Lymphoma Clinic Associate Professor Dermatology and Pathology University of California, San Francisco I HAVE NO RELEVANT RELATIONSHIPS
More informationInitial Diagnosis and Treatment 81 Male
Case SH2017-0359 Shiraz Fidai 1, Sandeep Gurbuxani 1, Girish Venkataraman 1, Gordana Raca 2, Madina Sukhanova 3, Michelle M Le Beau 3, Y. Lynn Wang 4, Mir Alikhan 4, Megan M.McNerney 4, Yuri Kobzev 4,
More informationChronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo
Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas NAIVE -B LYMPHOCYTE MEMORY CELL CLL MCL FL MZL Small cell size Low proliferation
More informationXIII. Molecular pathogenesis of transformed lymphomas
Hematological Oncology Hematol Oncol 2015; 33: 70 74 Published online in Wiley Online Library (wileyonlinelibrary.com).2221 Supplement Article XIII. Molecular pathogenesis of transformed lymphomas Davide
More informationImmunohistochemical and Immunogenetic Analyses of Ocular Adnexal Lymphoid Proliferation
Immunohistochemical and Immunogenetic Analyses of Ocular Adnexal Lymphoid Proliferation Toshinobu Kubota, Yasushi Yatabe, Shinobu Awaya, Junpei Asai and Naoyoshi Mori Department of Ophthalmology and Pathology,
More informationImmunophenotypic Profile of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
Hematopathology / IMMUNOPHENOTYPE OF LPL/WM Immunophenotypic Profile of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Sergej Konoplev, MD, PhD, L. Jeffrey Medeiros, MD, Carlos E. Bueso-Ramos,
More informationDETERMINATION OF A LYMPHOID PROCESS
Chapter 2 Applications of Touch Preparation Cytology to Intraoperative Consultations: Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid Disorders INTRODUCTION As discussed in Chap. 1,
More informationNormal hematopoiesis is a multistep process in
Molecular Hematology Interleukin-3 receptor α chain (CD123) is widely expresssed in hematologic malignancies original paper haematologica 2001; 86:1261-1269 http://www.haematologica.it/2001_12/1261.htm
More informationSignificant CD5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow
Hematopathology / CD5 Expression on Normal B Cells Significant CD5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow Franklin S. Fuda, DO, Nitin J. Karandikar, MD, PhD, and
More informationAggressive B-cell lymphomas and gene expression profiling towards individualized therapy?
Aggressive B-cell lymphomas and gene expression profiling towards individualized therapy? Andreas Rosenwald Institute of Pathology, University of Würzburg, Germany Barcelona, June 18, 2010 NEW WHO CLASSIFICATION
More informationJMSCR Vol. 03 Issue 06 Page June 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x An Indolent Natural Killer Cell Leukemia Presenting with Bilateral Ankle Arthritis and Low Grade Fever Abstract Author Subhash Chandra
More informationPeripheral blood Pleural effusion in a cat
Tools for the Diagnosis of Lymphoproliferative Diseases When is it difficult to diagnose lymphoproliferative disease? Persistent lymphocytosis consisting of small Lymph node aspirates containing an excess
More informationDaratumumab, a novel human CD38 monoclonal antibody for the treatment of B cell Non Hodgkin Lymphoma
Daratumumab, a novel human CD38 monoclonal antibody for the treatment of B cell Non Hodgkin Lymphoma Anna Vidal Department of Hemato Oncology IDIBAPS, Barcelona, Spain B cell lymphoid malignancies seen
More informationBeyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for
More informationACCME/Disclosures 4/13/2016. Clinical History
ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner
More informationAggressive B-Cell Lymphomas
Aggressive B-cell Lymphomas Aggressive B-Cell Lymphomas Stephen Hamilton Dutoit Institute of Pathology Aarhus Kommunehospital B-lymphoblastic lymphoma Diffuse large cell lymphoma, NOS T-cell / histiocyte-rich;
More informationAggressive B-cell Lymphomas
Neoplastic Hematopathology Update 2018 Aggressive B-cell Lymphomas Raju K. Pillai City of Hope National Medical Center I do not have any disclosures Disclosures Outline New entities and changes in WHO
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationUse of MYC, BCL2 and BCL6 FISH for investigations of high grade B cell lymphoma
Use of MYC, BCL2 and BCL6 FISH for investigations of high grade B cell lymphoma Dr Anthony Bench Haematopathology and Oncology Diagnostic Service Cambrıdge Unıversıty Hospitals NHS Foundatıon Trust Cambridge
More informationAbstract. Materials and Methods
Hematopathology / ANAYSIS OF BC-2 IN YMPHOMA AND HYPERPASIA Follicular ymphoma Can Be Distinguished From Benign Follicular Hyperplasia by Flow Cytometry Using Simultaneous Staining of Cytoplasmic bcl-2
More informationBurkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8
Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology
More informationLow-grade B-cell lymphoma
Low-grade B-cell lymphoma Patho-Basic 11. September 2018 Stephan Dirnhofer Pathology Outline Definition LPL, MBL/CLL/SLL, MCL FL Subtypes & variants Diagnosis including Grading Transformation Summary Be
More informationIntronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-hodgkin B-cell lymphoma
NEOPLASIA Brief report Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-hodgkin B-cell lymphoma Fabrice Jardin, Christian Bastard, Nathalie Contentin,
More informationMimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia
Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco Types of Lymphoid Hyperplasia Follicular hyperplasia (B-cells) Paracortical
More informationFLOW CYTOMETRIC ANALYSIS OF NORMAL BONE MARROW
XI International Conference Hematopoiesis Immunology Budapest, June 6-7, 2014 FLO CYTOMETRIC ANALYSIS OF NORMAL BONE MARRO Bruno Brando and Arianna Gatti Hematology Laboratory and Transfusion Center Legnano
More informationSmall B-cell (Histologically Low Grade) Lymphoma
Frequency of Lymphoid Neoplasms Small B-cell (Histologically Low Grade) Lymphoma Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital B-cell neoplasms 88% Diffuse large B-cell lymphoma
More informationPathology of the indolent B-cell lymphomas Elias Campo
Pathology of the indolent B-cell lymphomas Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas Antigen selection NAIVE -B LYMPHOCYTE MEMORY B-CELL MCL FL LPL MZL CLL Small cell
More informationLevels of expression of CD19 and CD20 in chronic B cell leukaemias
364 Academic Department of Haematology and Cytogenetics, The Royal Marsden Hospital and Institute of Cancer Research, London SW3, UK E Matutes N Farahat R Morilla D Catovsky Department of Internal Medicine,
More informationHematogones With Lambda Light Chain Restriction in a 4-Year-Old Boy With Burkitt Lymphoma: A Potential Diagnostic Pitfall
Hematogones With Lambda Light Chain Restriction in a 4-Year-Old Boy With Burkitt Lymphoma: A Potential Diagnostic Pitfall Tesha Guillory, MD, 1 Shiyong Li, MD, PhD, 1 Daniel J. Bergsagel, MD, 2 Elizabeth
More informationBCR-ABL1 positive Myeloid Sarcoma Nicola Austin
BCR-ABL1 positive Myeloid Sarcoma Nicola Austin Cytocell UK & Ireland User Group Meeting Jesus College, Cambridge 4 th - 5 th April 2017 Myeloid Sarcoma WHO Classification Tumours of Haematopoietic and
More informationDo Your Flow Cytometric LDTs. Validation Guidelines? Fiona E. Craig, MD University of Pittsburgh School of Medicine
Do Your Flow Cytometric LDTs Conform to the ICSH ICCS Validation Guidelines? Fiona E. Craig, MD University of Pittsburgh School of Medicine How should LDTs be validated? Accuracy Specificity Sensitivity
More informationMimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk.
Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco I have nothing to disclose regarding the information to be reported in this
More informationFlow Cytometric Analysis of CD5+ B Cells A Frame of Reference for Minimal Residual Disease Analysis in Chronic Lymphocytic Leukemia
Hematopathology / CD5+ -CELL NLYSIS Y FLOW CYTOMETRY Flow Cytometric nalysis of CD5+ Cells Frame of Reference for Minimal Residual Disease nalysis in Chronic Lymphocytic Leukemia Ritu Gupta, MD, 1 Paresh
More informationComposite mantle cell and follicular lymphoma. A case report
Human Pathology (2009) 40, 259 263 www.elsevier.com/locate/humpath Case study Composite mantle cell and follicular lymphoma. A case report Raquel B. Ilgenfritz MD a,, Agnès Le Tourneau MD a, Michel Arborio
More informationPrepared by: Dr.Mansour Al-Yazji
C L L CLL Prepared by: Abd El-Hakeem Abd El-Rahman Abu Naser Ahmed Khamis Abu Warda Ahmed Mohammed Abu Ghaben Bassel Ziad Abu Warda Nedal Mostafa El-Nahhal Dr.Mansour Al-Yazji LEUKEMIA Leukemia is a form
More informationEurekah Bioscience Collection
in Malignant 5/31/06 12:09 PM in Malignant to Leukemia and Lymphoma Eurekah Bioscience Collection in Malignant Sarah E. enrickson Elena M. artmann German Ott Andreas Rosenwald* The practice of clinical
More informationABERRANT EXPRESSION OF CD19 AND CD43
ABERRANT EXPRESSION OF CD19 AND CD43 IN A PATIENT WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA AND A HISTORY OF MANTLE CELL LYMPHOMA Yen-Chuan Hsieh, 1 Chien-Liang Lin, 2 Chao-Jung Tsao, 2 Pin-Pen Hsieh,
More informationPatterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure
Patterns of Lymphoid Neoplasia in Peripheral Blood Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure Dr Baltrucki has received an honorarium for his participation as a faculty presenter in this
More information3/2/2010. Case 1. Clinical History. Infectious Disease Pathology Specialty Conference Case 1
Case 1. Clinical History Infectious Disease Pathology Specialty Conference Case 1 A 6 year-old girl with a large left neck mass. Past medical history: Biliary cirrhosis secondary to extra hepatic biliary
More informationThe Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D.
The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D. OBJECTIVES 1. To understand how ordered Ig gene rearrangements lead to the development
More informationHematopathology Service Memorial Sloan Kettering Cancer Center, New York
SH2017-0334 t(14;18) Negative Follicular Lymphoma with 1p36 abnormality associated with In Situ Follicular Neoplasia with t(14;18) translocation Pallavi Khattar MD, Jennifer Maerki MD, Alexander Chan MD,
More informationLearn more about diffuse large B-cell lymphoma (DLBCL), the most common aggressive form of B-cell non-hodgkin s lymphoma 1
Learn more about diffuse large B-cell lymphoma (DLBCL), the most common aggressive form of B-cell non-hodgkin s lymphoma 1 Expression of B-cell surface antigens drives several non-hodgkin s lymphomas (NHLs)
More information